Fluigent (FLU) was founded by researchers from Curie Institute in Paris in 2003. With 21 employees today FLU owns a portfolio of patents or pending patents in flow control, microfluidic devices, polymers, colloids and analytical methods. FLU is an SME located in "Paris-Biotech" incubator. It was awarded the 2005 Innovative Technology Enterprises from the French Innovation Agency OSEO/ANVAR.

FLU‟s business is to develop, manufacture and commercialize instruments and OEM products for micro- and nanofluidics, bioanalytical applications and diagnosis.

FLU has the vocation to develop and commercialize devices dedicated to diagnostics based on its microfluidic technologies and analytical tools. FLU customers include academic and industrial research laboratories in physics, chemistry, biology, and clinical diagnostic centres in Europe, USA and Japan. We also offer OEM products for the pharmaceutical and diagnosis industry.


18 JANUARY 2022